Flex Pharma, Inc. FLKS was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came after the company was enlisted in the Nasdaq Biotechnology Index, effective Dec 21, 2015, before the market opened. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.58–$12.36 in the past one-month time frame.
In the last 30 days, the company has seen one downward estimate revision and the Zacks Consensus Estimate also moved lower, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Flex Pharma currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
A better-ranked bio-medical/gene stock is Achillion Pharmaceuticals, Inc. ACHN, which sports a Zacks Rank#1 (Strong Buy).
Is FLKS going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment